Skip to main content

Table 4 The relationship between lncRNA-ANRIL and SOX9 expression levels and the clinicopathology in patients with glioma

From: Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis

Factors

n

Relative expression of lncRNA-ANRIL

t

P

Relative expression of SOX9

t

P

Tumor grade

  

8.650

<0.001

 

6.621

<0.001

Grade I to II

79

2.47±0.35

  

0.39±0.04

  

Grade III to IV

63

2.02±0.27

  

0.44±0.05

  

Tumor diameter(cm)

  

3.602

<0.001

 

6.638

<0.001

≥4.51

77

2.29±0.31

  

0.45±0.04

  

<4.51

65

2.11±0.28

  

0.41±0.03

  

Distant metastasis

  

5.351

<0.001

 

5.027

<0.001

Yes

39

2.38±0.27

  

0.43±0.06

  

No

103

2.13±0.24

  

0.38±0.05

  

Family history of glioma

  

2.166

0.032

 

2.113

0.036

Yes

19

2.26±0.37

  

0.36±0.05

  

No

123

2.09±0.31

  

0.40±0.08

 Â